
Barbie gets real: New doll features insulin pump and glucose monitor
Mattel's latest Barbie was recently launched by Lila Moss, a British model who lives with type 1 diabetes. The doll comes with a visible insulin pump and a continuous glucose monitor, devices many people with diabetes rely on.
To some people, this might seem like just another version of the doll. But to kids living with type 1 diabetes — especially young girls — it's a big deal. This new Barbie is not just a toy. It's about being seen.
What is type 1 diabetes?
Type 1 diabetes is a condition where the body stops making insulin, the hormone that helps control blood sugar levels.
It's not caused by lifestyle or diet. It's an autoimmune condition (a disorder where the immune system mistakenly attacks healthy cells) and often starts in childhood.
People with type 1 diabetes need to take insulin every day, often through multiple injections or an insulin pump. They also need to check their blood sugar regularly, using finger pricks or a continuous glucose monitor worn on the skin (usually the upper arm).
Although type 1 diabetes can be effectively managed, there is no cure.
Millions of people across the world live with this condition, and numbers are on the rise. In Australia, type 1 diabetes affects more than 13,000 children and teens, while in New Zealand, around 2,500 children under 18 have type 1 diabetes. Globally, 1.8 million young people are affected.
Managing type 1 diabetes isn't easy for children
Young people with type 1 diabetes must think about their condition every day — at school, during sports, at sleepovers and even while playing. They may have to stop what they're doing and check their blood sugar levels. It can feel isolating and frustrating.
Stigma is a big issue for children and young people with type 1 diabetes. Some young people feel embarrassed using their insulin pumps or checking their blood sugar in public. One study found pre-teens with diabetes sometimes felt they received unwanted attention when using devices such as insulin pumps and glucose monitors.
Stigma can make young people less likely to take care of their diabetes, which can create problems for their health.
Seeing a Barbie with an insulin pump and glucose monitor could make a significant difference.
Children form their sense of identity early, and toys play a surprisingly powerful role in that process. While children with type 1 diabetes can often feel different from their peers, toys can help normalise their experience and reduce the sense of isolation that can come with managing a chronic condition.
Research shows toys and media such as books and TV shows reflecting children's experiences can boost self-esteem, reduce stigma and improve emotional wellbeing.
For girls especially, Barbie is more than a doll. She represents what is often perceived to be admired or desirable and this can influence how girls perceive their own bodies. A Barbie with a glucose monitor and insulin pump sends a clear message: this is part of real life. You're not alone.
That kind of visibility is empowering. It tells children their condition doesn't define them or limit their potential. It also helps challenge outdated stereotypes about illness and disability.
Some may worry a doll with a medical condition might make playtime too serious or scary. But in reality, play is how kids learn about the world. Toys that reflect real life — including health issues — can help children process emotions, ask questions, reduce fear and feel more in control.
A broader shift towards inclusivity and representation
Mattel's new Barbie shows diabetes and the devices needed to manage the condition in a positive, everyday way, and that matters. It can start conversations and help kids without diabetes learn what those devices are and why someone wears them. It builds understanding early.
Mattel has added to its range of Barbies in recent years to showcase the beauty that everyone has. There are now Barbies with a wide range of skin tones, hair textures, body types and disabilities — including dolls with hearing aids, vitiligo (loss of skin pigmentation) and wheelchairs. The diabetes Barbie is part of this broader shift toward inclusivity and should be applauded.
Every child should be able to find toys that reflect who they are, and the people they love.
This Barbie won't make diabetes go away. But she might help a child feel more seen, more confident, more like their peers. She might help a classmate understand that a glucose monitor isn't scary — it's just something some people need. She might make a school nurse's job easier when explaining to teachers or students how to support a student with diabetes.
Living with type 1 diabetes as a child is tough. Anything that helps kids feel a little more included, and a little less different, is worth celebrating. A doll might seem small. But to the right child, at the right moment, it could mean everything. — Reuters
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Free Malaysia Today
a day ago
- Free Malaysia Today
Pharma shares slump after Trump price threat
Donald Trump is targeting cutting US drug prices, which are among the world's highest. (AFP pic) PARIS : Shares in European pharmaceutical firms slumped on Friday following a threat by president Donald Trump to punish them if they don't lower prices for medicines in the US. Shares in Novo Nordisk, the Danish maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, saw shares drop 4.5% shortly after trading got under way in Copenhagen. Shares in Britain's AstraZeneca fell 2.8% in London, while Sanofi fell 1.1% in Paris. Meanwhile shares in Novartis shed 0.9% and Roche 1.0% after Trump announced Swiss goods will face a 39% tariff starting next week. Trump told major pharmaceutical firms Thursday to lower prices or face punishment, as he moved to give Americans relief from medicine costs much higher than elsewhere in the world. In letters to 17 drug companies published on his platform Truth Social, Trump said he wants the firms to work with his administration to institute a series of changes within 60 days. 'If you refuse to step up we will deploy every tool in our arsenal to protect American families from continued abusive drug pricing practices,' Trump wrote without specifying what the consequences would entail. Trump is following up on an executive order he signed in May to address US drug prices that are among the highest in the world – more than three times what people in similarly developed countries pay, the White House said Thursday.


Free Malaysia Today
2 days ago
- Free Malaysia Today
Trump warns pharma companies to cut prices or be punished
US drug prices are more than three times what people in similarly developed countries pay. WASHINGTON : US President Donald Trump told major pharmaceutical firms Thursday to lower prices or face punishment, as he moved to give Americans relief from medicine costs much higher than elsewhere in the world. In letters to 17 drug companies published on his Platform Truth Social, Trump said he wants the firms to work with his administration to institute a series of changes within 60 days. 'If you refuse to step up we will deploy every tool in our arsenal to protect American families from continued abusive drug pricing practices,' Trump wrote without specifying what the consequences would entail. Trump is following up an on executive order he signed in May to address US drug prices that are among the highest in the world – more than three times what people in similarly developed countries pay, the White House said Thursday. In the letters Trump said the response he has received so far to his order from companies have been 'more of the same: shifting blame' and policy changes that would in fact benefit the industry, not consumers. Key to the Trump plan is a 'Most Favored Nation' policy that pins the cost of drugs sold in the US to the lowest price paid by other countries for the same drug. Trump said Thursday he wants the companies to extend this pricing policy to medications used by older people under the government-backed health program Medicaid. He also wants this status to apply to new drugs, Trump said in the letters. 'Americans are demanding lower drug prices and they need them today,' Trump wrote.


Malay Mail
2 days ago
- Malay Mail
Justin Timberlake reveals ‘relentlessly debilitating' Lyme disease after world tour
LOS ANGELES, Aug 1 — Pop star Justin Timberlake told fans yesterday he has Lyme disease, a condition he described as 'relentlessly debilitating.' The 44-year-old former NSYNC frontman, whose world tour has just wrapped up, took to Instagram in reflective mood. 'This has been the most fun, emotional, gratifying, physically demanding, and, at times, grueling experience,' he said of a tour that was criticized by some fans as lackluster. 'Among other things, I've been battling some health issues, and was diagnosed with Lyme disease—which I don't say so you feel bad for me—but to shed some light on what I've been up against behind the scenes. 'Living with this can be relentlessly debilitating, both mentally and physically. When I first got the diagnosis I was shocked for sure. But, at least I could understand why I would be onstage and in a massive amount of nerve pain or just feeling crazy fatigue or sickness.' Lyme disease is caused by a bacteria often carried by ticks that live in woodlands throughout North America and Europe. Symptoms can include widespread pain, fatigue, and muscle weakness. In serious cases, patients could experience damage to the tissues, joints and immune system. The 'Can't Stop The Feeling' singer was in legal hot water last year after being arrested for drunk driving in a small town near New York. Timberlake, whose tumultuous relationship with Britney Spears was the inspiration for his 2002 smash 'Cry Me A River' later pleaded guilty to a lesser charge and was ordered to do community service. — AFP